JP2015532928A5 - - Google Patents

Download PDF

Info

Publication number
JP2015532928A5
JP2015532928A5 JP2015533220A JP2015533220A JP2015532928A5 JP 2015532928 A5 JP2015532928 A5 JP 2015532928A5 JP 2015533220 A JP2015533220 A JP 2015533220A JP 2015533220 A JP2015533220 A JP 2015533220A JP 2015532928 A5 JP2015532928 A5 JP 2015532928A5
Authority
JP
Japan
Prior art keywords
composition
shell
type
therapeutic agent
biodegradable polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015533220A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015532928A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/060922 external-priority patent/WO2014047439A1/en
Publication of JP2015532928A publication Critical patent/JP2015532928A/ja
Publication of JP2015532928A5 publication Critical patent/JP2015532928A5/ja
Pending legal-status Critical Current

Links

JP2015533220A 2012-09-20 2013-09-20 充填材料を含有する生体分解可能なマイクロカプセル Pending JP2015532928A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261703723P 2012-09-20 2012-09-20
US61/703,723 2012-09-20
PCT/US2013/060922 WO2014047439A1 (en) 2012-09-20 2013-09-20 Biodegradable microcapsules containing filling material

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018178572A Division JP2019014729A (ja) 2012-09-20 2018-09-25 充填材料を含有する生体分解可能なマイクロカプセル

Publications (2)

Publication Number Publication Date
JP2015532928A JP2015532928A (ja) 2015-11-16
JP2015532928A5 true JP2015532928A5 (enExample) 2016-10-20

Family

ID=50341971

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015533220A Pending JP2015532928A (ja) 2012-09-20 2013-09-20 充填材料を含有する生体分解可能なマイクロカプセル
JP2018178572A Pending JP2019014729A (ja) 2012-09-20 2018-09-25 充填材料を含有する生体分解可能なマイクロカプセル

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018178572A Pending JP2019014729A (ja) 2012-09-20 2018-09-25 充填材料を含有する生体分解可能なマイクロカプセル

Country Status (9)

Country Link
US (3) US20150265541A1 (enExample)
EP (1) EP2897593A4 (enExample)
JP (2) JP2015532928A (enExample)
KR (1) KR20150090038A (enExample)
AU (3) AU2013317899A1 (enExample)
BR (1) BR112015006087A2 (enExample)
HK (1) HK1214127A1 (enExample)
MX (2) MX2015003665A (enExample)
WO (1) WO2014047439A1 (enExample)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2538929A4 (en) 2010-02-25 2014-07-09 Univ Johns Hopkins DELAYED RELEASE OF THERAPIES IN A PART OF THE EYE
US10307372B2 (en) 2010-09-10 2019-06-04 The Johns Hopkins University Rapid diffusion of large polymeric nanoparticles in the mammalian brain
US9327037B2 (en) 2011-02-08 2016-05-03 The Johns Hopkins University Mucus penetrating gene carriers
WO2013110028A1 (en) 2012-01-19 2013-07-25 The Johns Hopkins University Nanoparticle formulations with enhanced mucosal penetration
US8962577B2 (en) 2012-03-16 2015-02-24 The Johns Hopkins University Controlled release formulations for the delivery of HIF-1 inhibitors
EP2825207B1 (en) 2012-03-16 2020-08-19 The Johns Hopkins University Non-linear multiblock copolymer-drug conjugates for the delivery of active agents
US11596599B2 (en) 2012-05-03 2023-03-07 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
WO2013166408A1 (en) 2012-05-03 2013-11-07 Kala Pharmaceuticals, Inc. Pharmaceutical nanoparticles showing improved mucosal transport
US9827191B2 (en) 2012-05-03 2017-11-28 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
WO2013166385A1 (en) 2012-05-03 2013-11-07 Kala Pharmaceuticals, Inc. Pharmaceutical nanoparticles showing improved mucosal transport
HK1208377A1 (en) 2012-05-04 2016-03-04 The Johns Hopkins University Lipid-based drug carriers for rapid penetration through mucus linings
US10568975B2 (en) 2013-02-05 2020-02-25 The Johns Hopkins University Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof
WO2015127368A1 (en) 2014-02-23 2015-08-27 The Johns Hopkins University Hypotonic microbicidal formulations and methods of use
EP3250184B1 (en) 2015-01-27 2024-12-18 The Johns Hopkins University Hypotonic hydrogel formulations for enhanced transport of active agents at mucosal surfaces
AR106018A1 (es) 2015-08-26 2017-12-06 Achillion Pharmaceuticals Inc Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
ES2908479T3 (es) 2015-08-26 2022-04-29 Achillion Pharmaceuticals Inc Compuestos para el tratamiento de trastornos inmunitarios e inflamatorios
US20170273911A1 (en) * 2016-03-23 2017-09-28 Boston Scientific Scimed Inc. Injectable microspheres
CN109790143A (zh) 2016-05-10 2019-05-21 C4医药公司 用于靶蛋白降解的胺连接的c3-戊二酰亚胺降解决定子体
EP3454862B1 (en) 2016-05-10 2024-09-11 C4 Therapeutics, Inc. Spirocyclic degronimers for target protein degradation
CN109641874A (zh) 2016-05-10 2019-04-16 C4医药公司 用于靶蛋白降解的c3-碳连接的戊二酰亚胺降解决定子体
WO2017197055A1 (en) 2016-05-10 2017-11-16 C4 Therapeutics, Inc. Heterocyclic degronimers for target protein degradation
SG11201811491YA (en) 2016-06-27 2019-01-30 Achillion Pharmaceuticals Inc Quinazoline and indole compounds to treat medical disorders
CA3028751A1 (en) 2016-07-01 2018-01-04 G1 Therapeutics, Inc. Pyrimidine-based antiproliferative agents
EP3532166B1 (en) * 2016-10-28 2020-09-16 Unilever N.V. A personal care composition comprising particles
EP3532025B1 (en) 2016-10-28 2021-02-24 Unilever N.V. Personal care compositions comprising surface-modified particles and non-volatile functionalised silicone
KR102632860B1 (ko) 2017-03-01 2024-02-02 아칠리온 파르마세우티칼스 인코포레이티드 의학적 장애의 치료를 위한 아릴, 헤테로아릴, 및 헤테로사이클릭 약학적 화합물
CN110769822A (zh) 2017-06-20 2020-02-07 C4医药公司 用于蛋白降解的n/o-连接的降解决定子和降解决定子体
JP2021519337A (ja) 2018-03-26 2021-08-10 シー4 セラピューティクス, インコーポレイテッド Ikarosの分解のためのセレブロン結合剤
WO2020041301A1 (en) 2018-08-20 2020-02-27 Achillion Pharmaceuticals, Inc. Pharmaceutical compounds for the treatment of complement factor d medical disorders
EP3846803A4 (en) 2018-09-06 2022-08-10 Achillion Pharmaceuticals, Inc. Macrocyclic compounds for the treatment of medical disorders
WO2020081723A1 (en) 2018-10-16 2020-04-23 Georgia State University Research Foundation, Inc. Carbon monoxide prodrugs for the treatment of medical disorders
KR102272566B1 (ko) * 2019-01-18 2021-07-05 주식회사 대하맨텍 인체에 자극이 없어 안전하고 생분해가 가능한 캡슐 및 그의 제조방법
WO2020149684A2 (ko) * 2019-01-18 2020-07-23 주식회사 대하맨텍 인체에 자극이 없어 안전하고 생분해가 가능한 캡슐 및 그의 제조방법
FR3091877B1 (fr) 2019-01-22 2023-06-16 Calyxia Compositions de detergence avec des propriétés olfactives améliorées
FR3091878B1 (fr) 2019-01-22 2023-06-16 Calyxia Compositions de produits d’entretien avec des propriétés olfactives améliorées
WO2020210805A1 (en) 2019-04-11 2020-10-15 The Johns Hopkins University Nanoparticles for drug delivery to brain
BR112021019669A2 (pt) 2019-04-12 2021-12-07 C4 Therapeutics Inc Composto, composição farmacêutica, método para tratar um transtorno, composto para uso na produção de um medicamento, e, uso de um composto no tratamento de um transtorno
EP4107166A4 (en) 2020-02-20 2024-06-26 Achillion Pharmaceuticals, Inc. HETEROARYL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT FACTOR D-MEDIATED DISORDERS
WO2021178920A1 (en) 2020-03-05 2021-09-10 C4 Therapeutics, Inc. Compounds for targeted degradation of brd9
ES3048084T3 (en) 2020-05-19 2025-12-09 Pharmacosmos Holding As Cyclin-dependent kinase inhibiting compounds for the treatment of medical disorders
JP7787164B2 (ja) 2020-09-23 2025-12-16 アキリオン ファーマシューティカルズ, インコーポレーテッド 補体媒介性障害の治療のための医薬化合物
WO2024184188A1 (en) * 2023-03-03 2024-09-12 Danmarks Tekniske Universitet A method for preparing microparticles for drug delivery

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001388A (en) * 1973-06-14 1977-01-04 Alza Corporation Ophthalmological bioerodible drug dispensing formulation
US4865846A (en) * 1988-06-03 1989-09-12 Kaufman Herbert E Drug delivery system
AU2001298061A1 (en) * 2000-12-13 2003-07-09 Purdue Research Foundation Microencapsulation of drugs by solvent exchange
US8425929B2 (en) * 2004-04-30 2013-04-23 Allergan, Inc. Sustained release intraocular implants and methods for preventing retinal dysfunction
WO2006041942A2 (en) * 2004-10-04 2006-04-20 Qlt Usa, Inc. Ocular delivery of polymeric delivery formulations
JP4856881B2 (ja) * 2005-02-01 2012-01-18 川澄化学工業株式会社 薬剤徐放システム
EP1931387A4 (en) * 2005-09-07 2012-07-11 Southwest Res Inst BIODEGRADABLE MICROTEILED PHARMACEUTICAL FORMULATIONS WITH IMPROVED RELEASE RATES
JP5201763B2 (ja) * 2007-02-28 2013-06-05 昇一 城武 異なる平均粒径サイズの粒子からなる混合微粒子カプセルの製造方法
US8071119B2 (en) * 2007-05-14 2011-12-06 Sustained Nano Systems Llc Controlled release implantable dispensing device and method
CA2700356C (en) * 2007-09-27 2013-07-09 Akina, Inc. Sol-gel phase-reversible hydrogel templates and uses thereof
WO2012054498A1 (en) * 2010-10-18 2012-04-26 Case Western Reserve University Polymeric microparticles

Similar Documents

Publication Publication Date Title
JP2015532928A5 (enExample)
JP4959328B2 (ja) 温度感応性状態変化ハイドロゲル組成物及びその製造方法
JP2012532120A5 (enExample)
KR101774342B1 (ko) 하이드로겔 마스크팩 조성물, 이를 통해 제조된 하이드로겔 마스크팩 및 이의 제조방법
ATE459344T1 (de) Verfahren zur herstellung einer gelatinefreie kapselschalenformulierung mit iota-carrageenan und kappa-carrageenan
MX357583B (es) Capsulas de nucleo-corteza.
MX2015012092A (es) Capsulas y comprimidos solidos de benzonatato de liberacion modificada.
CN102670563A (zh) 一种无明胶软胶囊的制备方法
CN103751791A (zh) 一种壳聚糖复合纳米凝胶固定化多层胶囊的制备方法
JP6173616B2 (ja) マイクロニードルシート及びその製造方法
CN108041674A (zh) 一种高效阻水防渗透胶囊及其制备方法
TW200526266A (en) Non-tabletted, chewable, individually dosed administration forms
CA3155876A1 (en) Non-animal softgel capsule formulations, methods of preparation, and methods of use thereof
JP2013173780A5 (enExample)
JP2016508789A5 (enExample)
AR090888A1 (es) Vehiculos de liberacion de composiciones pesticidas
CN201578439U (zh) 药物储库式除疤硅凝胶贴片
MX378261B (es) Formas de dosificación sólidas de liberación prolongada antieméticas.
CN107875139A (zh) 一种壳核α‑生育酚微胶囊及其制备方法
WO2013128328A3 (en) System and method for whitening teeth
CN103735419A (zh) 水合凝胶增白牙齿贴膜
CN101756941A (zh) 药物储库式除疤硅凝胶贴片及其制备方法
US20170367850A1 (en) Breast Prostheses with Phase Change Material
KR20150001510A (ko) 물 캡슐 제조 방법
JP2016513624A5 (enExample)